A portfolio built on stress-response vulnerabilities
NextAge is advancing multiple preclinical therapeutic programs designed to dismantle adaptive survival systems and restore sensitivity to therapy.
How we describe programs publicly
We present our pipeline at a high level to protect intellectual property while communicating strategic intent. Detailed program information is available under NDA.
Program areas
Resistance-enabling survival hubs
Programs targeting stress-adaptation control nodes implicated in therapy resistance.
Combination-enabling mechanisms
Programs designed to pair with standard-of-care agents to reduce escape and relapse.
Platform expansion
Ongoing discovery to identify additional stress-response vulnerabilities across tumor contexts.
Development stance
Translational plan
Biomarkers, pharmacodynamics, and tumor-context prioritization built in from the start.
Partnering readiness
Clear combination hypotheses and clinical positioning to support efficient development.
Portfolio optionality
Multiple shots on goal with shared biology and learnings across programs.